CyanoCapture


CyanoCapture is a biotech company focused on photosynthetic biomanufacturing, utilizing genetically engineered cyanobacteria powered by sunlight and fed on CO2 to synthesize high-value biomolecules. Their mission is to revolutionize drug manufacturing and industrial processes by providing low-energy, biological synthesis methods that are scalable and environmentally friendly. They aim to turn CO2 into valuable products, reducing emissions and creating economic opportunities.

Industries

biotechnology
genetics
life-science

Nr. of Employees

small (1-50)

CyanoCapture

Oxford, Oxfordshire, United Kingdom, Europe


Products

IFN-Alpha (photosynthetically produced)

Recombinant interferon-alpha produced via photosynthetic biomanufacturing from engineered cyanobacterial strains.

FGF2 (recombinant growth factor)

Fibroblast growth factor 2 produced via engineered photosynthetic microbes intended for research or therapeutic applications.

Peptide therapeutics (pipeline)

Peptide-based drug candidates produced via the photosynthetic platform; pipeline includes announced peptide product(s) and additional pharmaceutical candidates.

Industrial enzymes

Enzymes produced from engineered photosynthetic microbes for industrial applications.

Bioplastics and bio-graphite

Materials streams derived from processed cyanobacterial biomass intended for use as bioplastics or bio-derived graphite substitutes.

Biocrude oil and biochar

Upstream biomass conversion products including biocrude and biochar generated from processed cyanobacterial biomass.


Services

On-site photobioreactor deployment and integration

Design, installation and operation of photobioreactor systems integrated into point-source emission sites for CO2 capture and on-site biomanufacturing of biomass and target compounds.

Pilot-scale demonstrations and scale-up services

Execution of pilot and demonstration projects at 1,000 L and multi-thousand litre scale with support for scaling to 20,000 L and beyond, including continuous cultivation experiments and productivity characterisation.

IP and strain licensing

Licensing of engineered strains, cloning methods and related intellectual property for partners and customers seeking access to photosynthetic biomanufacturing capabilities.

Fixed supply agreements (product offtake)

Contracted supply agreements for produced biomolecules from planned scale-up facilities, with announced early-stage fixed-price offers for initial customers.

Expertise Areas

  • Photosynthetic biomanufacturing
  • Cyanobacterial strain engineering
  • Photobioreactor deployment and integration
  • Carbon capture and utilization (CCU)
  • Show More (6)

Key Technologies

  • Photobioreactors (closed tubular PBR systems)
  • CRISPR gene editing
  • Strain engineering and synthetic biology libraries
  • Continuous cultivation and automated harvest systems
  • Show More (5)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.